Under the agreement Medacta has a non-exclusive license to Mighty Oak’s patents related to the pedicle screw guides. Medacta also agreed to sell its MySpine Guides exclusively with Medacta pedicle screws through 2031.
“We are pleased to have resolved the ongoing litigation with Medacta and are excited to re-focus all internal resources on developing the next generation of presurgical planning and patient-specific solutions to enhance patient care,” Nick Byrne, Mighty Oak Medical vice president of sales and marketing, said in the release.
